NEWS On the Health Affairs Blog: Orphan Drugs, Pursuing Value, and Avoiding Unintended Effects of Regulations 5/04/17

In the latest post on the the IVI-sponsored Health Affairs blog series, Joshua Liao and Mark Pauly examine the role of government regulation of orphan drugs in rising drug prices, providing some specific examples and how they relate to the provisions of the Orphan Drug Act. Liao and Pauly also present some potential solutions to the problem, including policy and market approaches.

Read more here.